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The ligation of the left anterior descending coronary artery is the most commonly used
experimental model to induce myocardial infarction (MI) in rodents. A high mortality in
the acute phase and the heterogeneity of the size of the MI obtained are drawbacks
recognized in this model. In an attempt to solve the problem, our group recently
developed a new MI experimental model which is based on application of myocardial
ablation radio-frequency currents (AB-RF) that yielded MI with homogeneous sizes
and significantly reduce acute mortality. In addition, cardiac structural, and functional
changes aroused by AB-RF were similar to those seen in animals with MI induced
by coronary artery ligation. Herein, we compared mRNA expression of genes that
govern post-MI milieu in occlusion and ablation models. We analyzed 48 mRNAs
expressions of nine different signal transduction pathways (cell survival and metabolism
signs, matrix extracellular, cell cycle, oxidative stress, apoptosis, calcium signaling,
hypertrophy markers, angiogenesis, and inflammation) in rat left ventricle 1 week after MI
generated by both coronary occlusion and AB-RF. Furthermore, high-throughput miRNA
analysis was also assessed in both MI procedures. Interestingly, mRNA expression
levels and miRNA expressions showed strong similarities between both models after
MI, with few specificities in each model, activating similar signal transduction pathways.
To our knowledge, this is the first comparison of genomic alterations of mRNA and
miRNA contents after two different MI procedures and identifies key signaling regulators
modulating the pathophysiology of these twomodels that might culminate in heart failure.
Furthermore, these analyses may contribute with the current knowledge concerning
transcriptional and post-transcriptional changes of AB-RF protocol, arising as an
alternative and effective MI method that reproduces most changes seem in coronary
occlusion.
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INTRODUCTION
The ligation of the left anterior descending coronary artery is
a classical experimental model to induce myocardial infarction
(MI) in rodents. However, this method showed a high mortality
rate in the acute phase post-MI and large heterogeneity of the
MI size that are recognized drawbacks of this model. Antonio
et al. (2009) developed a new MI experimental protocol, which
is based on application of ablation radio-frequency currents
(AB-RF) in the myocardium. This technique, initially used as a
heart failure (HF) method, yielded MI with homogeneous sizes,
and significantly reduces acute mortality rate. Although cardiac
structural and functional changes aroused by AB-RF were similar
to those seen in animals with MI induced by coronary artery
ligation (Antonio et al., 2009), extensive comparison of molecular
signature of these models is yet unknown.
There are strong evidences of several upregulated,
downregulated, or stable mRNA expression during MI and
HF progression. Many authors assessed an expression pattern
in different MI phases and issues as cardiomyocytes responses
to remodeling were addressed in different studies, focusing
in differentially expressed genes (Dhalla et al., 2012; Sofia
et al., 2014; Katz et al., 2016; Kirk and Cingolani, 2016). These
changes may occur at multiple levels, including in transcription
regulation, epigenetic processes, mRNA stability, and more.
MicroRNAs (miRs), a specific group of 18–24 nucleotides
non-coding RNAs are compelling regulators that can both
destabilizing and inhibiting translation of mRNAs (Kukreja et al.,
2011).
To compare these two MI protocols, we performed the
evaluation of mRNA expression of nine different signal
transduction pathways (cell survival, cell cycle, oxidative stress,
apoptosis, molecules related to calcium signaling, cell growth
factors, transcription factors, angiogenesis, and inflammation) in
rat left ventricle with MI generated by experimental protocols
of coronary occlusion and AB-RF. Therefore, along with
identification of differentially expressed genes, we performed a
large-scale microRNA identification in these MI protocols. The
mRNA andmicroRNA transcriptomes analyses may help to draw
feasible molecular mechanisms associated with a particular MI
model that seldom would have functional significance alone.
Thus, AB-RF due its lack of complexity might be an effective and
fast method to achieve MI.
METHODS
Animals
Sixty-five male Wistar rats (∼230 g) were used in the present
work. The animals were cared for in compliance with the
Principles of Laboratory Animal Care, as formulated by the
National Institutes of Health (National Institutes of Health
publication no. 96-23, revised in 1996). The protocol was
approved by the Ethics Committee for Animal Care and Use at
the Universidade Nove de Julho, in Sao Paulo, Brazil (034/2012).
The animals were randomized into three groups: animals that
undergo to left coronary descendent artery ligation (Occlusion,
n = 37); animals that undergo to left ventricle RF ablation
(Ablation, n= 21); and animals that had thoracotomy but neither
occlusion or ablation were performed (Sham, n= 7).
Anterior Descending Coronary Artery
Ligation
This MI method was based on work by Johns and Olson (1954),
withminor adaptations. This technique is being routinely applied
to rat in our laboratory (Antonio et al., 2009; Manchini et al.,
2014). Rats were anesthetized with 4% halothane inhalation,
intubated and mechanically ventilated with positive pressure in
rodent ventilator (Harvard Model 683, Holliston, MA, USA).
After trichotomy, lateral thoracotomy was performed at the
place where the heart impacts on palpation. With the animal
in the supine position was made 2 cm incision in the skin
and dilatation of the pectoral and intercostal muscles with the
help of Kelly curved forceps. After dilatation of the intercostal
muscles, the ribs were isolated with the help of Kelly forceps and
retractor Stevenson adapted. Then it was held a pericardiotomy
and exposure of the heart to visualize the anterior descending
coronary artery (ADCA).
For “MI generation, ADCA was occluded to ∼3mm from
the origin of the aorta through 5.0 nylon suture. After being
checked the results of the suture, the retractor was removed,
lung hyperinflation is promoted and the thorax was closed by
purse string suture previously prepared around the incision
edges. Postoperative care as analgesia (meperidine, 20mg/kg, SC)
and search for signs of anorexia, fever, vomiting, or abnormal
respiration were conducted in all experimental animals.
Radio-Frequency Ablation
Under 4% halothane anesthesia and immobilization in the supine
decubitus position, the left thoracotomy was performed in the
fourth intercostal space. The ribs were separated by retractors.
After pericardium opening, the electrode (forceps) was placed
in position to gently embrace the heart, and the catheter tip
was placed on the LV anterolateral wall, perpendicularly to the
tissue. AB-RF lesions (one ablation/rat) were achieved using
a modified unipolar mode, following the procedure used by
Antonio et al. (2009) and Dos Santos et al. (2013). Briefly, a
custom-made catheter with a single electrode located at its tip
was used to deliver RF energy against an indifferent electrode
with a large area. The catheter tip was a single aluminum dome-
shaped electrode (similar to a round domed screw head), 4.5mm
in diameter and 4.0mm in length. This electrode was connected
to an electrically-insulated flexible coaxial cable that was able to
deliver very high frequency currents. A copper plate (14.6mm)
was located at the posterior aspect of the heart. Special steel
forceps designed to support the heart during AB-RF was used
as the indifferent electrode. The distal end of the forceps took
the shape of 2 small shells (0.9 cm in diameter). Given the large
surface of these shells compared with the rat heart, energy could
be delivered to the myocardium without a significant rise in
impedance. Thus, the cable was connected to the proximal end
of the forceps.
A commercially available RF generator (model TEB RF10;
Tecnologia Eletronica Brasileira Ltda, Sao Paulo, Brazil) was used
to create RF-Ab lesions. RF current (1000KHz) was delivered
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at constant power (12 watts) for 12 s. Power and impedance
was monitored during each application and the mean values
were recorded. An automatic power output shut down was
triggered if impedance exceeded 200 ohms. The damaged tissue
was characterized by the presence of a clear white disk-shaped
region of coagulation necrosis that appeared immediately after
current application. Then, the heart was instantly returned to
the thorax, pulmonary hyperinsuﬄation was performed, and a
previously made pursestring suture was used to close the chest.
A continuously monitored D2 electrocardiogram was performed
during the procedure. Ventricular Ab protocol was always lower
than 2 min and postoperative care was performed as stated
previously.
Transthoracic Doppler Echocardiograms
Animals from occlusion and ablation groups undergo to ECHO
examination to evaluate the infarct size 3 days after MI induction
using a HP SONOS 5500 (Philips Medical System, Andover,
MA) with a 12-MHz transducer at a depth of 2 cm, according to
previous reports (Antonio et al., 2009; Silva et al., 2014). Briefly,
under 4% halothane anesthesia, 2-dimensional and M-mode
images from the parasternal longitudinal, transverse, and apical
views were obtained and recorded on a 0.5-inch videotape. The
imaging analysis and measurements were performed oﬄine. MI
was detected by ECHO on the basis of subjective identification
of akinesis or dyskinesis. Measurements of end-diastolic (LVAd)
and end-systolic (LVAs) LV transverse areas were performed
in the 3 transverse planes (basal, medium, and apical) and
LV systolic function was estimated by the fractional area
change (FAC: LVAd—LVAs/LVAd× 100). Diastolic function was
assessed by calculating the peak E and A blood flow mitral
velocities and the E/A ratio. Sample volume of the pulsed wave
Doppler was positioned at the tips of the mitral valve leaflets
in an apical 4-chamber view. Only animals bearing infarct sizes
higher than 40% of LV in both procedures were included in the
experimental groups. An experiment cardiologist made a blind
analysis of all echocardiograms.
mRNA Quantification Analysis
Animals were euthanized by decapitation 1 week after each MI
protocols. An area from a remote MI site (septum) was collected
from each animal and used for comparative messenger RNA
expression using TaqMan microarray plates to identify mRNAs
that were differentially expressed among the different groups of
rat heart tissues; control, occlusion, and ablation MI samples.
Samples weighing between 0.2 and 0.5 g, were homogenized in
Trizol R© Reagent for extracting RNA according to manufacturer’s
instructions. Then, extraction was performed with equal volume
mixture containing phenol-chloroform-isoamyl alcohol in a
ratio of 25:24:1, followed by precipitation with 0.2 M sodium
acetate and 2 volumes of absolute ethanol. The precipitated
RNA was washed with 70% ethanol to eliminate the phenol and
salt residues, and solubilized in DEPC-water. The total RNA
extracted was treated with deoxyribonuclease 10 U RNase-free
for 1 h at 37◦C. The concentration of total RNA samples was
determined spectrophotometrically at a wavelength of 260 nm.
The RNA integrity was verified after gel electrophoresis in 1%
agarose containing 0.5µg/ml ethidium bromide, irradiation with
ultraviolet light. The quantification of the total RNA samples
was made using the NanoDrop ND-2000 spectrophotometer
apparatus (NanoDrop Products, Wilmington, DE, USA) where
1U A260 RNA corresponds to 40µg/ml. Samples were only used
free of contaminants (A260/A230∼ 1.8) and protein (A260/A280
= 1.8–2.0). The integrity of total RNA was assessed by observing
the proportion of bands related to 18S and 28S rRNA on
agarose gel electrophoresis 1% stained with SYBR R© Safe (Life
technologies). To eliminate genomic DNA contamination of the
samples, 1µg of total RNA (8 µL) was incubated with 1 unit (1
µL) of DNase I / RNase Free—(Invitrogen, USA) in the presence
of one solution containing 20mM Tris HCl, pH 8.4 and 2mM
MgCl2 for 15min at 37◦C, followed by incubation at 65◦C for
10min to inactivate the DNAse I.
After the above treatment, reverse transcription reaction
was performed (RT-PCR) for cDNA synthesis. At 1µg total
RNA treated were added 2µL of incubation buffer (50mM
KCl, Tris-HCl pH 8.4, 20mM MgCl2, 2.5mM), 1 unit of
reverse transcriptase (1µl) (Invitrogen) 2µl Randon Primer
(Invitrogen) 0.8µL of oligonucleotides (dNTPs, 100mM) and
4.2µL of ultrapure H2O to a final reaction of 20µL. The samples
were then subjected to the following incubations: 25◦C for
10min, 37◦C for 120min, 85◦C for 5min. After the reaction, the
cDNA samples were kept at −20◦C for further Real-time PCR
analysis.
The reaction of polymerization chain in real time (Real-Time
PCR) combines PCR amplification with automated fluorescent
detection. Amplification and data acquisition were performed
with TaqMan probe using Abi Prism 7500 Fast equipment
(Applied Biosystems) as previously described (Silva et al., 2014).
The fluorescence excitation capture was performed on each PCR
amplification cycle, providing a real-time quantification of the
sequences of genes of interest. The protocol used for the Real time
PCR reactions was: 1.0µl of cDNA was added 5µL of Solution
TaqMan Fast Universal Master Mix 2X (Applied Biosystems,
USA) and sufficient water to 10µL reaction in each well of
the 96 well-plate. The samples were applied in duplicate, and
then incubated at 95◦C for 20 s, and passed through 40 thermal
cycles at 95◦C for 3 s, 60◦C for 30 s. TaqMan Array plates 96—
Well-Plate FAST been customized by Applied Biosystems/Life
Technologies according to the chosen genes.
All reactions were subjected to the same conditions of
analysis and normalized by ROX passive reference dye signal
for correction of fluctuations in reading due to changes in
volume and evaporation over the reaction. The results, expressed
in Ct value refer to the number of PCR cycles required
for the fluorescent signal reaches the detection threshold.
The differentially expressed genes were normalized by the
expression level of the housekeeping genes GAPDH or 18S
subunit ribosomal RNA, which expression was shown to remain
unchanged under experimental conditions. Fast SDS 1.4 software
(Applied Biosystems) was used for data processing. The 1Ct
values of the samples were determined by subtracting the average
Ct value of themRNA of the target gene from the average Ct value
of the GAPDH housekeeping gene or 18S rRNA. The 2−11Ct
parameter was used to express the relative expression data.
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NanoString nCounter Assay for miRNA
Profiling
We profiled miRNAs using NanoString nCounter-miRNA
expression analyses (NanoString Technologies, Seattle,
Washington) that uses molecular barcodes and single-molecule
imaging to detect and count RNAs without PCR amplification
to analyze the global expression of miRNAs in the same total
RNA samples used for mRNA quantification. Those samples
were isolated from septum 1 week after both MI procedures of
occlusion and ablation. The method quantifies 423 endogenous
rat miRNAs (based in miRBase, version 17) of each septal
specimen remote to MI area in two plates that accommodated
the 24 samples (n= 8/group).
Raw data were processed using the NanoStringNorm R
package (Waggott et al., 2012). The raw data were log2
transformed and normalized using the mean of the six positive
controls, which were used to calculate a scaling factor in each
column (lane/sample) as suggested by NanoString. The internal
positive spike controls were present in each reaction to account
for minor differences in hybridization, purification, or binding
efficiencies. The data were further background corrected by
subtracting the mean of the six negative controls followed by
quantile normalization.
Total RNA (100 ng) was used as input for nCounter
miRNA sample preparation reactions and the reactions were
performed, as per the manufacturer’s instructions (NanoString
Technologies). Small RNA sample preparation involves the
ligation of a specific DNA tag onto the 3′ end of each mature
miRNA. These tags normalize the melting temperatures of the
miRNAs and provide a unique identification for each miRNA
species in the sample. Excess tags were then removed, and
the resulting material was hybridized with a panel of miRNA:
tag-specific nCounter capture and barcoded reporter probes.
Hybridized probes were then purified and immobilized on a
streptavidin-coated cartridge using the nCounter Prep Station
(NanoString Technologies). Data collection was carried out
on the nCounter Digital Analyzer (NanoString Technologies)
following manufacturer’s instructions to count individual
fluorescent barcodes and quantify target RNA molecules present
in each sample. For each assay, a high-density scan (600 fields of
view) was performed.
The nCounter miRNA data was also confirmed through
cross-platform validation in 10 randomly selected study samples
using the TaqMan probes on the 7500 Fast Real Time PCR
System. Furthermore, differentially expressed miRNAs were also
quantified by Real-time PCR (data not shown). The average
Pearson correlation coefficient was 0.70 (0.60–0.80) between the
two platforms, thus confirming the robustness of the nCounter
platform.
Statistical Analysis
Data were analyzed with GraphPad Prism software (La Jolla, CA,
USA). The Shapiro-Wilk test was used to verify normality and
error variances. Results were evaluated using two-way ANOVA
complemented by Tukey test was used to detect differences
between three groups at sample with normal distribution. A p ≤
0.05 was considered significant and the results are expressed as
mean± standard error of the mean (SEM).
RESULTS
Mortality Rate Comparison
Twelve of 37 rats (32%) died post occlusion-induced MI, mainly
because large infarction sizes. In contrast, only one rat died after
RF-Ab of unspecific cause. This animal showed the commitment
of 42% of the LV area, dismissing the idea of extensive Ml above
average as a cause of death.
TaqMan Microrrays Assays
Addressing to changes in remote MI mRNA expression
after coronary occlusion compared to control, we observed
38 differentially expressed mRNAs involved in extracellular
matrix remodeling [collagen III 1a (COLIII1a):1.59-fold;
collagen I 1a (COLI1a): 3.09-fold; tenascin: 3.32-fold and
matrix metallopeptidase 9: 2.41-fold], inflammation mediators
[interleukin 6 (IL6): 1.06-fold; tumor necrosis factor receptor
1a (TNFRSFLA): 1.40-fold and tumor necrosis factor, alpha
(TNFa): 1.13-fold] and a survival marker (AKT1: 1.65-fold) that
were found to be upregulated after coronary occlusion compared
to control.
Genes involved in apoptosis signaling [Bcl2 associated X
protein (Bax): 1.10-fold and p 53: 1.11-fold] were found to
be upregulated, whereas mitogem activated protein kinase 14
(MAPK14) and mitogem activated protein kinase 1 (MAPK1)
were found to be downregulated (−1.07- and −1.09-fold,
respectively) after coronary occlusion compared to control.
Among oxidative stress genes, two were found to be upregulated
after coronary occlusion [glutathione peroxidase 4 (GPX4):
1.34-fold and heat shock protein 12b (HSPA12B): 1.34-fold],
whereas catalase and superoxide dismutase 1 were found to be
downregulated by−1.03- and−1.04-fold, respectively.
Expressions of hypertrophy biomarkers [endothelin:
1.78-fold; natriuretic peptide A and B: 4.48- and 2.18-fold,
respectively; protein kinase C, alpha: 1.13-fold and nuclear
factor of activate T-cells cytoplasmic, calcineurin—dependent
3 (NFATC3): 1.10-fold] were found to be upregulated after
coronary occlusion compared to control. Interestingly,
calcineurin like EF hand protein 2, angiotensin converting
enzyme (ACE1) and angiotensin II receptor type 1a (−1.77-,
−1.05- and −1.19-fold, respectively) were found to be
downregulated after coronary occlusion.
Two myofilamentar protein expressions were analyzed,
myosin, heavy chain beta was found to be upregulated
(1.59-fold) whereas myosin, heavy chain alpha was found
to be downregulated (−1.52-fold) compared to control. The
genes involved in calcium kinetics [phospholamban: 1.10-
fold and solute carrier family 8 (sodium/calcium exchange),
member 1: 1.38-fold] were found to be upregulated after
coronary occlusion compared to control. However, also involved
in calcium kinetics, ryanodine receptor 2, ATPase, calcium
transporting cardiac muscle, slow twitch 2 (ATP2A2) and
calsequestrin 2 (−1.25, −1.06-, −1.05-fold, respectively) were
found to be downregulated after MI occlusion-induced. Vascular
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endothelial growth factor A (VEGFA, −1.50-fold) was found
to be downregulated after occlusion when compared to
control.
Among metabolism-related genes [hexoquinase I: 1.59-fold;
uncopling protein 2: 1.56-fold; solute carrier family 2 (facilited
glucose transporter) member 1: 1.08-fold and taffazin: 1.10-fold]
were found to be upregulated after coronary occlusion. Apart
from these, phosphofructokinase expression (−1.53-fold) was
found to be downregulated after coronary occlusion compared
to control.
Comparing remote MI mRNA expression after ablation
protocol to control, we found 38 differentially expressed
genes. Extracellular matrix remodeling genes were found to be
upregulated [collagen III 1a (COLIII1a):1.65-fold; collagen I 1a
(COLI1a): 3.87-fold; tenascin: 6.68-fold and transforming growth
factor, beta 1 (TGF1b): 1.57-fold] when compared to control.
Also, inflammation mediators genes [interleukin 6 (IL6): 1.17-
fold and tumor necrosis factor, alpha (TNFa): 1.83-fold] showed
increased expression after myocardial ablation in comparison
with control.
Furthermore, mRNA expressions of apoptosis signaling
genes [Bcl2 associated × protein (Bax): 1.30-fold, p 53: 1.82-
fold, mitogem activated protein kinase 1 (MAPK1): 1.92-fold],
survival effector (AKT1): 2.25-fold, calcium kinetics [ryanodine
receptor 2: 2.29-fold; ATPase, calcium transporting cardiac
muscle, slow twitch 2 (ATP2A2): 1.92-fold; calsequestrin 2:
1.93-fold; phospholamban: 3.36-fold and solute carrier family 8
(sodium/calcium exchange), member 1: 3.29-fold], metabolism-
related genes [hexoquinase I: 2.74-fold; uncopling protein 2:
2.35-fold; solute carrier family 2 (facilited glucose transporter)
member 1: 1.90-fold; phosphofructokinase: 1.18-fold; NADH
dehydrogenase (ubiquinone) 1 alpha subcomplex 3 (NDUFA3):
2.27-fold and taffazin: 1.58-fold] were also found to be
upregulated after ablation. In addition, myosin heavy chain beta
(2.73-fold)] was found to be upregulated after ablation compared
to control, however, the expression of the alpha isoform remained
unchanged after ablation.
Among oxidative stress genes analyzed, two were found to
be upregulated after ablation [glutathione peroxidase 4 (GPX4):
2.27-fold and catalase: 2.29-fold], whereas superoxide dismutase
1 was found to be downregulated by −1.22-fold when compared
to control. In addition, expression of vascular endothelial growth
factor A (VEGFA, −1.50-fold) was found to be downregulated
after ablation when compared to control.
Most of the hypertrophy biomarkers [angiotensin converting
enzyme (ACE1): 1.12-fold; angiotensin converting enzyme 2
(ACE2): 1.58-fold; angiotensin II receptor type 1a: 1.69-fold;
endothelin: 2.22-fold; natriuretic peptide A and B: 1.91- and
2.21-fold, respectively; protein kinase C, alpha: 2.29-fold; nuclear
factor of activate T-cells cytoplasmic, calcineurin—dependent 3
(NFATC3): 2.22-fold; insulin like growth factor (IGF1): 1.55-
fold] were found to be upregulated after ablation compared to
control. Among these protein kinase C, beta (−1.25-fold) was
found to be downregulated after ablation.
Analyzing changes in cardiac mRNA expression in occlusion
compared to ablation, we observed a smaller number of
differentially expressed mRNA (nineteen genes) that were
found to be differently expressed after occlusion than when
comparison was performed against control). Genes involved in
extracellular matrix remodeling [collagen III 1a (COLIII1a):1.25-
fold; tenascin: 2.01-fold; matrix metallopeptidase 9: 2.03-
fold and transforming growth factor, beta 1 (TGF1b): 1.42-
fold], survival marker (AKT1: 1.37-fold), apoptosis signaling
[mitogem activated protein kinase 14 (MAPK14): 1.21-fold],
calcium kinetics [phospholamban: 6.16-fold; solute carrier
family 8 (sodium/calcium exchange), member 1 (SLC8A1):
2.39-fold; calsequestrin 2: 2.04-fold and ATPase, calcium
transporting cardiac muscle, slow twitch 2 (ATP2A2): 2.05-
fold], metabolism-related genes [hexoquinase I: 1.72-fold;
uncopling protein 2: 1.51-fold; solute carrier family 2 (facilited
glucose transporter) member 1: 1.08-fold and taffazin: 1.75-
fold and phosphofructokinase: 1.80-fold] were found to be
upregulated after coronary occlusion when compared to ablation
protocol.
None oxidative stress genes were differently expressed
comparing both MI procedures. Regarding to inflammatory
response genes, only tumor necrosis factor receptor, member 1a
mRNA (TNFRSFLA,−1.05-fold) was found to be downregulated
in occlusion when compared to ablation. Expressions of
hypertrophy biomarkers [calcineurin like EF hand protein 2:
1.72-fold; angiotensin converting enzyme 2 (ACE2): 1.99-fold
and insulin like growth factor 1 (IGF1):1.68-fold] were found
to be upregulated after occlusion compared to ablation. Protein
kinase C, gamma (−1.23-fold) was found to be downregulated
after occlusion when compared to ablation. All data referring to
Taqman Realtime PCR are summarized on Table 1.
High Throughput miRNA Analysis
From 423 miRNAs, we only found eight differentially expressed
miRNAs among experimental groups. This low detection support
the idea that, besides particular differences in miRNA expression
between occlusion and ablation procedures, only few miRNAs
showed differentially expressed among total miRNA (<2%
of total miRNA). Following, we highlighted the differentially
expressed miRNAs detected on NanoString platform.
The data show that mir-221 presented a method-specific
switch in expression; occlusion had higher levels of thesemiRNAs
than ablation. Similarly, miR-34c and mir-93 expressions were
higher expressed in occlusion at 1 week compared to control, and
also in occlusion compared to ablation.
We also identified miRNAs with changes in expression
only after occlusion. Specifically, mir-301 and mir-17-5p
showed different expression levels after occlusion, while mir-301
expression decreased, we observed an increased in mir-17-5p
expression compared to control.
The mir-9 expression detected was similar between occlusion
and ablation and different when compared to control, whereas
both diminished. Ablation showed diminished expressions of
mir-542-5p and mir-1949 compared to control and occlusion.
Together, these results show that there are few changes in
miRNAs content between MI methods 1 week after infarction.
All data regarding to miRNA quantification are presented on
Tables 2–4.
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TABLE 1 | Altered significantly mRNA content (p ≤ 0.05) after myocardial
infarction.
Gene ID mRNA description OC × SH AB × SH OC × AB
Log2 fold Log2 fold Log2 fold
EXTRACELLULAR MATRIX
84032 COL3A1 1.60* 1.65* unaltered
29393 COL1A1 3.10*** 3.90*** 1.25***
59086 TGF1B unaltered 1.58* 1.42*
116640 TNC 3.32*** 6.68*** 2.01*
81687 MMP9 2.41*** unaltered 2.03***
INFLAMMATION
24498 IL6 1.07*** 1.18* unaltered
25625 TNFRSFLA 1.41* unaltered −1.05*
24835 TNFa 1.13* 1.83*** unaltered
APOPTOSIS
24887 BAX 1.11* 1.31* unaltered
24842 TP53 1.11* 1.82*** unaltered
81694 MAPK14 −1.07*** unaltered 1.21*
116590 MAPK1 −1.09*** 1.92*** unaltered
OXIDATIVE STRESS
29323 GPX4 1.35* 2.28* unaltered
24248 CAT −1.04*** 2.29*** unaltered
311427 HSPA12B 1.34* unaltered unaltered
24786 SOD1 −1.05*** −1.23* unaltered
ANGIOGENESIS
11651 AKT1 1.65*** 2.26* 1.37***
83785 VEGFA −1.50*** −1.51* unaltered
HYPERTROPHY
24310 ECA −1.06* 1.13* unaltered
302668 ECA2 unaltered 1.58* 1.99***
24323 EDN1 1.78* 2.22*** unaltered
24602 NPPA 4.49* 1.91* unaltered
25105 NPPB 2.18*** 2.22* unaltered
24482 IGF1 unaltered 1.68* 1.68*
24681 PRKCG unaltered unaltered −1.23***
24680 PRKCA 1.13* 2.29*** unaltered
308965 CHP2 −1.78* unaltered 1.72*
24180 AGTR1A −1.20*** 1.70*** unaltered
361400 NFATC3 1.10*** 2.23*** unaltered
CELL SURVIVAL
29556 MYH6 −1.52* 2.73* unaltered
29557 MYH7 1.60*** unaltered unaltered
CALCIUM SIGNALING
689560 RYR2 −1.30* 2.30*** unaltered
29693 ATP2A2 −1.07*** 1.92* 2.05*
29209 CASQ2 −1.05*** 1.94*** 2.04***
64672 PLN 1.11*** 3.36*** 6.16***
29715 SLC8A1 1.38*** 3.29*** 2.39*
METABOLISM
25058 HK1 1.59*** 2.75*** 1.72*
54315 UCP2 1.56*** 2.36* 1.51*
24778 SLC2A1 1.09*** 1.90* 1.75***
(Continued)
TABLE 1 | Continued
Gene ID mRNA description OC × SH AB × SH OC × AB
Log2 fold Log2 fold Log2 fold
65152 PFKM −1.54*** 1.19* 1.80***
691001 NDUFA3 1.13*** 2.27*** unaltered
363521 TAZ 1.10*** 1.59* unaltered
Gene ID refers to NCBI database numbers. OC × SH refers to Occlusion group vs. Sham
animals, AB × SH refers to Ablation group compared to Sham animals, OC × AB refers
to the comparison of both MI protocols. *p ≤ 0.05, ***p ≤ 0.001, unaltered refers to p >
0.05. More details are provided in Methods Section.
DISCUSSION
Data from transcriptomes have opened a window for more
integrated analysis of both qualitative and quantitative changes
in global mRNA expression at a particular time point of any
biological system (Agnetti et al., 2007). In the last decade, there
have been several efforts to dissect out cardiac mRNA and
proteome in a wide array of cardiovascular diseases (McGregor
and Dunn, 2006) using different animal models or plasma
samples collected from human patients (Seenarain et al., 2010;
Haas et al., 2011; Silbiger et al., 2011; Drastichova et al.,
2012; Chowdhury et al., 2013; Marshall et al., 2014; Petriz and
Franco, 2014). While novel biomarkers were identified from
some of these studies (Haas et al., 2011; Silbiger et al., 2011;
Chowdhury et al., 2013), authors reported general alterations in
the cardiac transcriptome and proteome profile that suggested
changes in Ca2+ handling proteins (Seenarain et al., 2010),
energy metabolism proteins (Jin et al., 2006; Meng et al., 2009),
and mediators of apoptotic signaling (Drastichova et al., 2012;
Marshall et al., 2014; Petriz and Franco, 2014).
Here, we attempted to achieve differentially expressed mRNA
of remote area of MI between coronary occlusion and by radio
frequency ablation in rats. Heretofore, we believe our study is
the first report that compares differentially mRNA expression
profile and large-scale miRNA analysis of these different MI
procedures, in order to establish ablation-induced MI as an
alternative experimental MI method, with the advantages of
uniformity of MI sizes and low mortality rates. Surprisingly, we
observed more mRNA expression similarities than differences
between these protocols.
Extracellular matrix (ECM) components are important
for mechanical support and effective functioning of the
cardiovascular system. Therefore, alteration of the ECM may
directly result in changes of mechanical properties and functional
impairment. The ECM also plays significant roles in tissue
remodeling in stress responses. Several extracellular matrix
genes take part of the cardiac remodeling after MI. In tune
with earlier reports (Roy et al., 2006; Manchini et al., 2014),
mRNA modifications regarding to cardiac remodeling were
observed in our experimental groups. mRNA expression analysis
revealed significant upregulation of most genes after both
occlusion and ablation compared to control. We found an
increased tenascin (TNC) mRNA expression in both occlusion
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TABLE 2 | MiRNAs that were altered significantly (p ≤ 0.05) after myocardial infarction induced by occlusion compared to Sham.
Column ID p-value (OC vs. SH) Mean ratio (OC vs. SH) Fold Change (OC vs. SH)
rno-miR-221 0.000626783 6.98409 6.98409
rno-miR-301b 0.0350184 0.49866 −2.00537
rno-miR-34c 0.0415997 2.63543 2.63543
rno-miR-93 0.00615468 1.82695 1.82695
rno-miR-9 0.024583 0.328826 −3.04112
rno-miR-17-5p 0.047911 1.74863 1.74863
TABLE 3 | MiRNAs that were altered significantly (p ≤ 0.05) after myocardial infarction induced by ablation compared to Sham.
Column ID p-value (AB vs. SH) Mean Ratio (AB vs. SH) Fold Change (AB vs. SH)
rno-miR-1949 0.0117833 0.231907 −4.31208
rno-miR-542-5p 0.00367377 0.544582 −1.83627
rno-miR-9 0.0464964 0.414557 −2.41221
TABLE 4 | MiRNAs that were altered significantly (p ≤ 0.05) after myocardial infarction induced by occlusion compared to ablation.
Column ID p-value (AB vs. OC) Mean ratio (AB vs. OC) Fold change (AB vs. OC)
rno-miR-1949 0.0350587 0.270379 −3.69851
rno-miR-221 0.00071974 0.155874 −6.41545
rno-miR-542-5p 0.0117105 0.586736 −1.70435
rno-miR-34c 0.0157985 0.247443 −4.04134
rno-miR-93 0.0027246 0.494091 −2.02392
and ablation. Tenascin is sparsely detected in the normal
adult myocardium, but reappears when the heart remodels its
structure in response to pathologic insults, such as acute MI
(Willems et al., 1996; Imanaka-Yoshida et al., 2001; Sato et al.,
2006; Odaka et al., 2008), myocarditis (Imanaka-Yoshida et al.,
2002; Sato et al., 2002; Morimoto et al., 2005), hibernation
(Frangogiannis et al., 2002), ischemia-reperfusion (Taki et al.,
2010), hypertensive cardiac fibrosis (Nishioka et al., 2007),
chronic cardiac rejection (Franz et al., 2010), and some cases of
dilated cardiomyopathy (DCM) (Tamura et al., 1996; Tsukada
et al., 2009) closely associated with inflammation. Several studies
suggest that TNC could help tissue reconstruction of the edge of
the residual myocardium as a de-adhesion protein. TNC could
loosen strong adhesion of cardiomyocytes (Imanaka-Yoshida
et al., 2001, 2004) and upregulate the expression and activity of
matrix metalloproteinases (MMPs) (Collins et al., 2004). In fact,
expression ofmatrixmetalloproteinase 9 was found to be induced
after occlusion but remained unaltered after ablation, indicating
that this particular increased expression may be consequent to
TNC stimulation. Most matrix cellular proteins are minimally
expressed in normal young adult hearts, but are markedly
upregulated following cardiac injury. Matrix cellular proteins
induced in the infarcted heart appear to serve as transducers of
key molecular signals in cardiac repair and act as modulators
of cell migration, proliferation, and adhesion (Frangogiannis,
2012).
Fibrosis is often considered to be the end inflammatory
reaction, and both stimuli generated by occlusion and ablation
were able to increase collagen I mRNA content. Regarding to
collagen III, the mRNA expression remained unchanged. This
data is in consonance with other reports that indicated an
augmentation in expression of collagen fibers type I as the end
product when tissue is repaired during heart failure in animal
models and human patients (Stefanon et al., 2013; Yabluchanskiy
et al., 2013), while collagen III is quickly synthetized and
gradually switched to collagen I fibers. A high expression of
TGF1b in occlusion group compared to ablation suggested that
there would be different pathways activated after this procedure.
TGF-β1 is a persistent stimulus in the chronic and inappropriate
wound healing phase that is marked by hypertrophic scarring
and eventual stiffening of the entire myocardium, ultimately
leading to the pathogenesis of heart failure following MI
(Zeglinski et al., 2016). Moreover, TGFβ1 is a key pro-fibrotic
cytokine that is markedly elevated in experimental MI, and anti-
TGF gene therapy mitigates cardiac remodeling by affecting
cardiac fibrosis and infarct tissue dynamics (Okada et al.,
2005).
In the infarcted myocardium, necrotic cardiomyocytes release
danger signals, activating an intense inflammatory response.
Inflammatory pathways play a crucial role in regulation of a
wide range of cellular processes involved in injury, repair, and
remodeling of the infarcted heart. Pro-inflammatory cytokines,
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such as tumor necrosis factor α and interleukin 1, are
markedly upregulated in the infarcted myocardium and promote
adhesive interactions between endothelial cells and leukocytes
by stimulating chemokine and adhesion molecule expression
(Saxena et al., 2016).
In fact, we found that some genes involved in inflammation
were upregulated after both occlusion and ablation. Upregulation
of all these mRNAs after MI procedures could be due to an
establishment of a secondary inflammation that accomplishes
MI by necrosis and other cell death mechanisms as reported
by earlier studies (Manchini et al., 2014; Saxena et al.,
2016). Importantly, inflammation mediator expressions were
mostly unaltered when occlusion and ablation were compared,
indicating the same activation pathways, there was an increased
mRNA expression of most interleukin analyzed in both
procedures when compared to control. TNF receptor mRNA,
for instance, showed increased expression in both procedures
when compared to control, and presented a downregulation after
occlusion when compared to ablation. This difference might
indicate a variation in the time course and extension of stimulus
that leads to inflammation. Several reports on the expression
status of these mRNAs in occlusion-induced MI are available—
and there is a consensus that inflammation plays an important
role after cardiomyocytes death (Bao et al., 2008; Zhu et al., 2015).
Our study also revealed an upregulation of Bax and p53
mRNA after both procedures compared to control, although
both genes remained unaltered compared among procedures,
corroborating that the MI protocols show the same mRNA
expression pattern. It has been reported earlier that MI
presented an important upregulation of mitochondria-related
pro-apoptotic members to meet increased stimulation after
MI procedures (Xu et al., 2015). In occlusion, we observed
a downregulation of mitogen activated protein kinases 1
and 14 when compared to control. These two kinases have
several functions, while MAPK1 act as an integration point
for multiple biochemical signals, and are involved in a wide
variety of cellular processes such as proliferation, differentiation,
transcription regulation and development, the MAPK14 is
member of p38 MAPK family, responsive to stress stimuli,
such as cytokines, ultraviolet irradiation, heat shock, and
osmotic shock, and are involved in cell apoptosis, differentiation
and autophagy. These intracellular mitogen-activated protein
kinases (MAPKs) signaling cascades play a key role in the
pathogenesis of cardiac and vascular disease. ERK1/2, a member
of the MAPKs, is concerned with the regulation of cell
proliferation, differentiation, survival, and apoptosis. Although,
most researchers have maintained that the phosphorylation
of ERK1/2 played an important role in protecting against
myocardial I/R injury (Clark et al., 2007), others have shown
that ERK1/2 phosphorylation may aggravate myocardial cell
injury (El-Mahdy et al., 2016). There is strong in vivo
evidence that activation of the p38 mitogen-activated protein
kinase (MAPK) family of stress-activated kinases exacerbates
myocardial injury following prolonged ischemia (Clark et al.,
2007). Pro-inflammatory cytokines such as IL-1 and tumor
necrosis factor alpha (TNFα), which are potent stimuli for the
p38 MAPK pathway, are elevated in the infarcted heart and
appear to be detrimental for post-MI myocardial remodeling and
progression to heart failure (Aukrust et al., 2005).
Oxidative stress-related mRNA presented markedly
expression in occlusion and ablation when compared to
control, although showed similar expression in comparison
between MI procedures. Reactive oxygen species (ROS) such
as superoxide anions (·O−2 ) and hydroxyl radicals (·OH) cause
the oxidation of membrane phospholipids, proteins, and DNA
(McCord, 1985) and have been implicated in a wide range of
pathological conditions including ischemia-reperfusion injury
(Chen et al., 2001), neurodegenerative diseases (Mizuno et al.,
1998) and aging (Trifunovic et al., 2004).
Under physiological conditions, their toxic effects can be
prevented by scavenging enzymes such as superoxide dismutase
(SOD), mitochondrial phospholipid hydroperoxide glutathione
peroxidase (GPX4), and catalase as well as by other non-
enzymatic antioxidants. However, when the production of ROS
exceeds the capacity of antioxidant defenses, oxidative stress
might have a harmful effect on the functional and structural
integrity of biological tissue. ROS cause contractile failure and
structural damage in the myocardium (Toussaint et al., 1993).
The importance of oxidative stress is increasingly emerging with
respect to a pathophysiological mechanism of LV remodeling
responsible for heart failure progression.
We identified GPX4 as the only oxidative stress molecule
that showed increased mRNA expression after both procedures
compared to control. GPX gene overexpression inhibited the
development of LV remodeling and failure after MI, which
might contribute to the improved survival (Shiomi et al., 2004).
These findings not only extended the previous observation
that employed antioxidants, but also revealed the major role
of ROS in the pathophysiology of myocardial remodeling.
These effects were associated with the attenuation of myocyte
hypertrophy, apoptosis, and interstitial fibrosis (Shiomi et al.,
2004). Similarly, overexpression of the GPX gene attenuated
myocardial remodeling and preserved diastolic function in
diabetic heart (Matsushima et al., 2006). Therefore, therapies
designed to interfere with oxidative stress by using GPX could
be beneficial to prevent myocardial remodeling and failure.
Superoxide dismutase 1 is the primary mitochondrial
antioxidant enzyme and is essential for maintaining normal cell
development and function. Overexpression of the SOD1 gene
has been shown to be beneficial in various animal models of
cardiac diseases (Yen et al., 1996; Chen et al., 1998). Interestingly,
we found to be a downregulation of SOD1 mRNA after MI
procedures compared to control. SOD1 gene overexpression
also elevated levels of myocyte catalase and mitochondrial GSH,
which might also act together with SOD1 against oxidative stress
(Khaper et al., 2003). Catalase gene was differently expressed in
each procedure compared to control. The expression increase
in ablation could be related to the lesion extension after MI
induction (Tsutsui et al., 2009).
Upregulation of hypertrophic markers after MI suggests an
activation of a mechanism that promotes enlargement of the
heart chambers as a compensative strategy to pathophysiologic
state. Hence, it could be suggested that differences concerning
hypertrophy in ablation when compared to control is an
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indicative of severity of stimulus triggered by this MI procedure
(Zannad et al., 2010; Gaggin and Januzzi, 2013). Ligation of
coronary artery provokes an augmentation on hypertrophic
markers, such as the cardiac natriuretic peptide A content, that
showed significant upregulation when compared to ablation. The
natriuretic peptides represent the gold standard for biomarkers in
HF, and the understanding about their biology and their clinical
use have both grown exponentially since their introduction.
Structurally conserved across multiple species, a number of
structurally similar natriuretic peptides have been identified:
atrial natriuretic peptide (ANP), urodilantin (an isoform of
ANP), B-type natriuretic peptide (BNP), C-type natriuretic
peptide and Dendroaspis natriuretic peptide (Cea, 2005). Of
these, ANP and BNP are transcribed and primarily produced
in the myocytes of atria and ventricles, respectively (Mukoyama
et al., 1991), both are produced in response to myocardial stretch
due to pressure or volume overload (Kinnunen et al., 1993),
conditions commonly found in HF. The biological functions
of ANP and BNP include various compensatory mechanisms
such as natriuresis, diuresis, and vasodilation (Cody et al., 1986;
Marcus et al., 1996).
Myofilamentar fibers also are important markers of
hypertrophy. Myosin isoform beta was upregulated after
MI procedures compared to control, which is in agreement
to previous report where myosin over-expression is related as
a molecular sign of overloaded myocardium (Gupta, 2007).
Although an augmentation of mRNA expression was observed
when experimental groups were compared to control, there were
no expression changes between both MI procedures. A major
shift in the myosin isoform distribution occurs during pathologic
hypertrophy mediated by pressure and volume overload. This
hypertrophy is associated with induction of βMHC at the expense
of αMHC. This change from the α- to β-MHC phenotype is taken
as a hallmark of pathologic hypertrophy, which is more intense
in pressure-overload than in volume-overload hypertrophy
(Gupta, 2007).
Particularly, all five genes related to calcium dynamic showed
altered mRNA expression in our study. Drastic increase in
the level of phospholamban and sodium calcium exchange
SLC8A1 mRNAs were observed after MI generated by ablation
compared to both occlusion and control. Failing heart muscle
generally exhibits distinct changes in intracellular calcium (Ca2+)
handling, including impaired removal of cytosolic Ca2+; reduced
Ca2+ loading of the cardiac sarcoplasmic reticulum (SR) with
downregulation of SR Ca2+-ATPase 2 (SERCA2); and defects
in SR Ca2+ release accompanied by impairment of cardiac
relaxation and systolic function (Morgan et al., 1990; Marx et al.,
2000). Sodium-calcium exchange (NCX) is the major Ca2+ eﬄux
mechanism of ventricular cardiomyocytes. Consequently, the
exchanger plays a critical role in the regulation of cellular Ca2+
content and hence contractility (Ottolia et al., 2013).
On the other hand, calsequestrin 2, cardiac ryanodine receptor
and ATPase, calcium transporter were downregulated after
coronary occlusion compared to control. Calsequestrin (CSQ2),
as the major Ca2+ binding protein in the sarcoplasmic reticulum
of cardiac myocytes, communicates changes in the luminal
Ca2+ concentration to the cardiac ryanodine receptor (RYR2)
channel (Gaburjakova et al., 2013). Combined with biochemical
observations highlighting the Ca2+ dependence of the CSQ2-
RYR2 interaction, these results indicate that the changes in RYR2
activity caused by luminal Ca2+ may be presumably attributed to
the CSQ2 dissociation from the channel complex; and thus, it is
highly likely that CSQ2 plays an active role in communicating
changes in [Ca2+] to the RYR2 channel (Gaburjakova et al.,
2013).
The metabolic adaptation of heart glycolysis to substrate
availability, workload, and hormones has been known for many
years (Taegtmeyer, 1994; Stanley et al., 1997) and the clinical
relevance of glucose metabolism to heart diseases has been
reviewed (Taegtmeyer, 1994; Depré et al., 1998).Six mRNA
implied to the metabolism of cardiomyocytes were relevant
in our expression investigation. All six genes were found to
be upregulated after MI induced by occlusion and ablation
compared to control, a common expression pattern seem
before in our mRNA quantification. Phosphosfructokinase 1,
a tetrameric enzyme that phosphorylates fructose-6-phosphate
to fructose-1,6-bisphosphate, committing glucose to glycolysis
(Opie, 1978), was decreased after occlusion, despite the fact that
it was more marked after ablation, both compared to control.
An augmentation of phosphofructokinase mRNA in occlusion
compared to ablation might indicate a more intense metabolic
rate after hypoxia, to reverse cell damage and death.
Two detected mRNA in this group, NAD dehydrogenase 1
alpha 3 and taffazzin (TAZ), increased after both MI procedures
compared to control. So far, there are no clear reports on
taffazin expression; while some authors observed a remarkable
over 90% decrease in TAZ mRNA expression during the
development of HF in rats and humans, others reported that
its expression remains unchanged after MI (Athéa et al., 2007;
Harjot et al., 2009). The NADPH oxidase family (Nox) is
a major and dedicated cellular ROS generation system in
cardiac myocytes and many other cell types, including neurons
(Lambeth, 2004; Bedard and Krause, 2007). It has been suggested
that decreases in NAD+/NADH ratio, which have been observed
in mitochondrial diseases or metabolic diseases such as diabetes,
promote reductive stress (Ido, 2007; Ying, 2008). Increased
NADPH level facilitates the reduction of glutathione, which
serves as an important antioxidant mechanism. It should be
mentioned that ischemia elevates NADH level (NAD+/NADH
ratio declines; Ying, 2008).
VEGFa, usually referred to as VEGF, acts as a key player
in vasculogenesis and angiogenesis. VEGFa mRNA was found
to be downregulated after both MI procedures compared to
control. Zhao et al. (2010) found that VEGFa levels within
the infarcted myocardium were persistently suppressed post
MI. VEGFR expression was significantly increased only at the
border zone at day 1, but not in the later stages. The expression
of VEGFa/VEGFR remained unchanged in the noninfarcted
myocardium.
On the other hand, Akt1 was upregulated exclusively after
MI procedures compared to control. Multiple signaling pathways
downstream of Akt1 control cell survival, growth, metabolism,
cell cycle progression, as well as motility of vascular cells
(Somanath et al., 2006). Akt1 signaling might be involved in
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the regulation of several aspects of cardiac function and repair
following an ischemic injury. Akt1 signaling seems to promote
fibrosis in post-MI hearts. Akt1 function in cardiac fibrosis
and hypertrophy is supported by multiple studies using both
overexpression of Akt1 in heart (Nagoshi et al., 2005; Shiojima
et al., 2005; Shiojima and Walsh, 2006) and Akt1 deletion
(Shimizu et al., 2010) models. Although lack of Akt1 enhances
LV damage and apoptosis in cardiomyocytes immediately after
I/R injury, in a longer term, it improves cardiac function and LV
remodeling after MI (Shimizu et al., 2010).
miRNA Analysis
In the current study, we found only few microRNAs are
differentially expressed between both MI models or compared
to control. All differentially expressed miRNA expression
were validated with Real time PCR and presented decreased
expressions after ablation compared to occlusion as observed in
nCounter analyzes. In response to ischemia or I/R, cardiac cells
including cardiomyocytes, cardiac fibroblasts, and endothelial
cells undergo variable miRNA dysregulation. These changes can
be apparent as early as 15 min after coronary artery ligation
and may last for hours, days, or months (Zhou et al., 2016).
This dysregulation may comprise a mix of protective and
deleterious effects. Following very brief ischemia or reperfusion,
such changes in miRNA expression might be relevant to early
cell survival. A prolonged ischemia and/or reperfusion will cause
permanent injury to the heart, and changes in miRNA expression
may be pertinent to apoptotic status and other chronic processes
including cardiac fibrosis and remodeling (Zhou et al., 2016).
In our occlusion protocol, we observed an enhanced
expression of miR-221. Notwithstanding, we detected an
increased ANP and BNP mRNA expression levels after 1 week.
These mRNA increments observed in MI generated by occlusion
is well established. Upregulation of miRNA-221 is also related
to antiapoptotic effects in cancer cells (Zhou et al., 2016)
and showed pro-proliferative, pro-migration, and antiapoptotic
effects in vascular smooth muscle cells (Zhou et al., 2016).
The miRNA-221 is significantly upregulated in patients with
hypertrophic cardiomyopathy (HCM) and in a mouse model
of cardiac hypertrophy and heart failure induced by pressure
overload (Su et al., 2015). In vitro overexpression of miR-
221 alone is sufficient to increase the size of cardiomyocytes,
accompanied by enhanced expression levels of atrial natriuretic
peptide (ANP) and brain natriuretic peptide (BNP) (Wang et al.,
2012). However, the in vivo roles and molecular mechanisms of
miR-221 in the regulation of cardiac remodeling remain unclear.
Our study identified an upregulation of miR-34c after
occlusion compared to control, and its upregulation compared
to ablation. Reports showed that miR-34c is induced after acute
ischemic damage (Greco et al., 2009), miR-34b and miR-34c
belong to an evolutionary conserved miRNA family that plays
a fundamental role in the p53 tumor suppressor network (He
et al., 2007). Since MI procedures promotes p53-dependent
apoptosis (Fiordaliso et al., 2001), it is tempting to speculate that
the p53/miR-34 axis may be involved in a MI-induced death
pathway.
Panguluri et al. (2013) identified a significant elevation of
miR-301a as a key modulator in diabetic condition. Loss of
function approach in in vitromodel (H9C2 cells) using miR-301a
inhibitor was used to test if the increase in miR-301 has a role in
regulation of Kv4.2 gene expression, a voltage-gated K+ channel.
We observed a decreased miR-301 and miR-93 expressions in
occlusion group compared to ablation. Computational analysis
of the Homo sapiens and Mus musculus RyR2-3′UTR revealed
conserved binding sites for miR-93. These results demonstrate
that miR-93 negatively regulates RyR2-3′UTR, which could lead
to a decreased RyR2 protein expression (Chiang et al., 2014).
In fact, we, analyzing downstream, observed a decrease in RyR2
mRNA expression in occlusion model compared to control.
MiR-17 was identified as a novel Apaf-1-targeting miRNA
(Song et al., 2015). The delivery of exogenous miR-17 suppressed
the apoptotic protease activating factor 1 (Apaf-1) expression
and consequently attenuated formation of the apoptosome
complex containing caspase-9, as demonstrated by co-
immunoprecipitation and immunocytochemistry. Furthermore,
miR-17 suppressed the cleavage of procaspase-9 and the
subsequent activation of caspase-3, which is downstream of
activated caspase-9. Together, these results demonstrated the
potential of miR-17 as an effective anti-apoptotic agent (Song
et al., 2015). We detected an increased expression of miR-17-5p
only after occlusion procedure. Moreover, Li et al. (2013)
investigated the role of miR-17 in cardiac matrix remodeling
following myocardial infarction (MI). Using real-time PCR,
miR-17 was up-regulated most dramatically: 3.7-fold and 2.4-
fold in the infarct region 3 and 7 d post-MI, respectively, and
2.4-fold in the border zone at d 3 compared to sham control (P<
0.01). Thus, it suggests that miR-17 participates in the regulation
of cardiac matrix remodeling and provides a novel therapeutic
approach using miR-17 inhibitors to prevent remodeling and
heart failure after MI (Li et al., 2013).
Wang et al. (2010) evidenced that miR-9 can suppress
myocardin expression, a transcriptional cofactor of NFATc3
expressed at a relatively low level in cardiomyocytes under
physiological conditions. However, it can be up-regulated
by hypertrophic stimulation and consequently mediate
hypertrophic signals. Administration of miR-9 could attenuate
cardiac hypertrophy and ameliorate cardiac function. We
observed a diminished miR-9 expression on both MI procedures
compared to control, corroborating the data presented by
Wang et al. (2010), whereas miR-9 suppression might increase
cardiac hypertrophy by NFATc3 stimulation. In fact, we
also observed an increased NFATc3 mRNA expression
after occlusion and ablation 1 week-post MI compared
to sham.
To the best of our knowledge, reports of miR-542 and miR-
1949 expressions in health or damaged cardiac tissue were not
yet described. We found a downregulation of both miRNAs
in ablation compared to occlusion and control. MiR-542-5p
may induce double-strand DNA breaks and reactive oxygen
species accumulation in transfected cells (Faraonio et al., 2012).
In addition, Yoon et al. (2010) suggested that survivin is a
direct target of miR-542-3p and growth inhibition by miR-
542-3p may have a potential utility as an anti-cancer therapy.
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The expression of miR-1949 was found to be deregulated
and abundant in the rat bladder following spinal cord injury.
Bioinformatics demonstrated that retinoblastoma 1, which is
involved in tumorigenesis, is a target gene of miR-1949 (Wang
et al., 2015), but still there was not a clear relation to the
myocardium.
CONCLUSION
We have identified transcriptional modifications in remote area
of rat myocardium after MI induced by occlusion and ablation.
Our findings pointed out that myocardium reacts, besides
different insults, with more similarities than differences in areas
remote to MI. Cardiac mRNA signatures after MI generated
by both protocols were found to cause alterations in almost
the same genes. This indicates a pattern in the way the tissue
deals with the injury, although the response magnitude varies
from one procedure to another. Notwithstanding, few miRNAs
were detected to be differently expressed between occlusion and
ablation experimental groups. Evaluation of mRNA expression
of an increased number of genes and proteome would lead
to better understanding of the miRNA targets associated
with pathophysiological states seen in both MI procedures.
Considering all aspects addressed in this study, we compared a
genic and post-transcriptional modifications signatures in both
methods and concluded that RF-Ab might be an alternative
protocol to achieve MI with lower rates of animals’ mortality and
with a simple and reproducible method and mostly importantly,
with activation of resembling signal pathways. However, we
hope to address to more detailed analyses and pathway
intersections in others studies in current development in our
laboratory.
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